What You Should Know
The Deal: Sensei Biotherapeutics has acquired Faeth Therapeutics in a stock-for-stock transaction. Concurrently, Sensei raised a massive $200M in private placement financing to fuel the combined company.The Asset: The centerpiece of the deal is PIKTOR, an oral drug
Read More
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Solve PI3K Resistance































































